Sarah Lane

Sarah Lane

Ask VT AI
View News Summary
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • S&P Global beats Q3 estimates, raises guidance, and plans divestitures amid strong ratings demand and profitability.
  • AI-driven tech rally boosts S&P and Nasdaq, but macro risks loom as Fed, politics, and energy markets add uncertainty.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • S&P Global beats Q3 estimates, raises guidance, and plans divestitures amid strong ratings demand and profitability.
  • AI-driven tech rally boosts S&P and Nasdaq, but macro risks loom as Fed, politics, and energy markets add uncertainty.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Sarah Lane